Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-02-20 Option Award | 2025-02-21 8:16 pm | N/A 2035-02-19 | Caribou Biosciences Inc. | CRBU | Sacks Natalie Director | 40,500 | $0 | 40,500 (Direct) | View |
| 2024-02-20 Option Award | 2024-02-22 5:08 pm | N/A 2034-02-19 | Caribou Biosciences Inc. | CRBU | Sacks Natalie Director | 39,500 | $0 | 39,500 (Direct) | View |
| 2023-02-21 Option Award | 2023-02-23 5:12 pm | N/A 2033-02-20 | Caribou Biosciences Inc. | CRBU | Sacks Natalie Director | 21,500 | $0 | 21,500 (Direct) | View |
| 2022-12-21 Option Award | 2022-12-23 7:00 pm | N/A 2032-12-20 | Zymeworks Inc. | ZYME | Sacks Natalie Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2022-01-28 Option Award | 2022-02-01 4:07 pm | N/A 2032-01-27 | Harpoon Therapeutics Inc. | HARP | Sacks Natalie Chief Medical Officer | 155,000 | $0 | 155,000 (Direct) | View |
| 2021-12-20 Option Award | 2021-12-21 5:38 pm | N/A 2031-12-19 | Caribou Biosciences Inc. | CRBU | Sacks Natalie Director | 27,500 | $0 | 27,500 (Direct) | View |
| 2021-11-11 Option Award | 2021-11-15 4:03 pm | N/A 2031-11-11 | Harpoon Therapeutics Inc. | HARP | Sacks Natalie Chief Medical Officer | 155,000 | $0 | 155,000 (Direct) | View |
Ownership | 2021-07-22 8:57 pm | N/A 2028-06-11 | Caribou Biosciences Inc. | CRBU | Sacks Natalie Director | 0 | $0 | 90,900 (Direct) | View |
| 2021-05-06 Option Award | 2021-05-07 8:45 pm | N/A 2031-05-05 | Zymeworks Inc. | ZYME | Sacks Natalie Director | 9,000 | $0 | 9,000 (Direct) | View |
| 2021-01-28 Option Award | 2021-01-29 8:00 pm | N/A 2031-01-27 | Harpoon Therapeutics Inc. | HARP | Sacks Natalie Chief Medical Officer | 80,000 | $0 | 80,000 (Direct) | View |